Cargando…

What's new on circulating tumor cells? A meeting report

Circulating tumor cells (CTCs) provide unique information for the management of cancer patients. The 7th International Symposium on Minimal Residual Cancer has focused on state of the art research, including exciting advances in understanding the biology of metastasis, CTCs and tumor dormancy. Parti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lianidou, Evi S, Mavroudis, Dimitris, Sotiropoulou, Georgia, Agelaki, Sophia, Pantel, Klaus
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949631/ https://www.ncbi.nlm.nih.gov/pubmed/20727231 http://dx.doi.org/10.1186/bcr2601

Ejemplares similares

Advances in circulating tumor cells (ACTC): from basic research to clinical practice
por: Lianidou, Evi S, et al.
Publicado: (2013)

Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2009)

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
por: Tzanikou, Eleni, et al.
Publicado: (2019)

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR
por: Strati, Areti, et al.
Publicado: (2011)

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2011)

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2008)

Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2015)

Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy
por: Spiliotaki, Maria, et al.
Publicado: (2014)

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse
por: Saloustros, Emmanouil, et al.
Publicado: (2011)

Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer
por: Lianidou, E S, et al.
Publicado: (2013)

What is new in the liver sinusoids? meeting report, 16th International Symposium on Cells of the Hepatic Sinusoid (ISCHS)
por: Rombouts, Krista, et al.
Publicado: (2011)

Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy
por: Strati, Areti, et al.
Publicado: (2023)

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer
por: Polioudaki, Hara, et al.
Publicado: (2015)

PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients
por: Markou, Athina, et al.
Publicado: (2020)

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes
por: Spiliotaki, Maria, et al.
Publicado: (2017)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer
por: Strati, Areti, et al.
Publicado: (2013)

Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting
por: Kalamarides, Michel, et al.
Publicado: (2011)

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
por: Kuske, Andra, et al.
Publicado: (2016)

Meeting report of the Mosquito Kolymbari Meeting 2013
por: Povelones, Michael, et al.
Publicado: (2013)

Use of Oral Cholera Vaccine in Complex Emergencies: What Next? Summary Report of an Expert Meeting and Recommendations of WHO
por: Chaignat, Claire-Lise, et al.
Publicado: (2007)

An overview of viral oncology in Italy - report from the Pavia meeting on solid tumors
por: Perfetti, Vittorio, et al.
Publicado: (2012)

Brain tumor epidemiology in the era of precision medicine: The 2017 Brain Tumor Epidemiology Consortium meeting report
por: Johnson, Kimberly J., et al.
Publicado: (2017)

Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting
por: Strati, Areti, et al.
Publicado: (2023)

RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA
por: Giannopoulou, Lydia, et al.
Publicado: (2017)

Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
por: Strati, Areti, et al.
Publicado: (2019)

Meeting report: Signal transduction meets systems biology
por: Louis-Dit-Sully, Christine, et al.
Publicado: (2012)

Meeting report of Ctenopalooza: the first international meeting of ctenophorologists
por: Ryan, Joseph F., et al.
Publicado: (2016)

Meeting report of the 2016 bone marrow adiposity meeting
por: van der Eerden, Bram, et al.
Publicado: (2017)

AGBT meeting report
por: Bhatt, Ami S., et al.
Publicado: (2018)

Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
por: Papadaki, Maria A, et al.
Publicado: (2014)

IFSC 2020 Meeting Report
por: Lappin, Terry
Publicado: (2021)

KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer
por: Mastoraki, Sofia, et al.
Publicado: (2020)

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies
por: Rounis, Konstantinos, et al.
Publicado: (2022)

SMBE Satellite Meeting on Reticulated Microbial Evolution 2014—Meeting Report
por: Dagan, Tal, et al.
Publicado: (2014)

Meeting report: the Human Genome Meeting (HGM) 2019 in Seoul, Korea
por: Solano, Angela, et al.
Publicado: (2019)

The Annual Meeting of the Thai Gynecologic Cancer Society 2019: Meeting report
por: Charoenkwan, Kittipat, et al.
Publicado: (2019)

TT2020 meeting report on the 16th Transgenic Technology Meeting
por: Hinttala, Reetta, et al.
Publicado: (2021)

Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting
por: Miller, Mark Steven, et al.
Publicado: (2021)

Advancing brain tumor epidemiology – multi-level integration and international collaboration: The 2018 Brain Tumor Epidemiology Consortium meeting report
por: Johnson, Kimberly J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_25s3heg1ts0ui2v3ciq2lmbkrg